332 - COVID-19 Research Update: How Well COVID-19 Vaccines Work Against Variants
Public Health On Call
The Johns Hopkins Bloomberg School of Public Health
4.6 • 644 Ratings
🗓️ 11 June 2021
⏱️ 21 minutes
🧾️ Download transcript
Summary
In this episode, Dr. Josh Sharfstein talks with Hopkins researchers who break down three papers looking at the effectiveness of different COVID-19 vaccines against variants of concern. Carli Jones, a graduate student at the Johns Hopkins School of Medicine, talks about some good news from a study looking at the effectiveness of Pfizer's vaccine against the variants found in the UK and South Africa. Greg Rosen, a PhD candidate, discusses a preprint study that assesses the effectiveness of the Chinese CoronaVac vaccine against the variant identified in Brazil. Dr. Nikolas Wada talks about a lab-based study assessing the potential effectiveness of mRNA vaccines against the B.1.617 variant discovered in India. These researchers are part of the Hopkins novel coronavirus research consortium, with many summaries of new studies available at http://ncrc.jhsph.edu.
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Welcome to Season 4 of Public Health On Call, a podcast from the Johns Hopkins Bloomberg School of Public Health. |
| 0:13.0 | I'm Josh Sharfstein, Vice Dean for Public Health Practice and Community Engagement, and a former Commissioner of Health in Baltimore City. |
| 0:20.0 | Our goal is to bring |
| 0:21.7 | scientific evidence and experience to current topics in public health through engaging interviews |
| 0:27.1 | with scientists, community leaders, policy experts, public health officials, clinicians, and more. |
| 0:32.8 | If you have ideas or questions for us to cover, please email us at public health question at jhhhu.edu. |
| 0:40.4 | That's public health question at jhhu.edu for future podcast episodes. |
| 0:46.4 | Today, our topic is how well COVID-19 vaccines work against variants of the coronavirus. |
| 0:53.6 | I hear from three scientists who are part of the novel |
| 0:56.5 | coronavirus research compendium at Johns Hopkins. |
| 0:59.7 | The compendium is online at ncrc.j.j.svh. |
| 1:05.0 | . |
| 1:06.4 | First, Carly Jones, a graduate student |
| 1:09.0 | at the Johns Hopkins School of Medicine. She will discuss |
| 1:12.2 | the study published in the New England Journal of Medicine on the effectiveness of the |
| 1:16.6 | Pfizer vaccine against the variants recognized in the United Kingdom and South Africa. |
| 1:22.7 | Spoiler alert. Some good news here. Then I'll speak to Greg Rosen, a PhD candidate in international |
| 1:30.1 | health at the Johns Hopkins-Wilmberg School of Public Health. We'll talk about a pre-print |
| 1:35.3 | study led by researchers at the University of Florida and the University of Sao Paulo. This study |
| 1:41.1 | assessed the effectiveness of the Chinese coronavirus vaccine in healthcare workers in Brazil, |
| 1:48.0 | with the focus being the Brazil variant. |
| 1:51.0 | Finally, I'll talk to Dr. Nicholas Wada about a preprint study from New York University, |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from The Johns Hopkins Bloomberg School of Public Health, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of The Johns Hopkins Bloomberg School of Public Health and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.